Why today’s ‘Magnificent Seven’ stocks have mediocre long-term prospects at best
By Press Room
2 Mins read
“ “Whoever coined the expression ‘Magnificent Seven’ for these companies presumably didn’t see the movie.”” — Robert Arnott We have no idea…
Opinion: We’ll all breathe easier if business shares recycling costs with taxpayers
By Press Room
4 Mins read
No one wants tons of waste polluting the environment. Yet over the past few years, some voices in the environmental movement have…
The ‘Barbenheimer’ buzz may be over, but consumer enthusiasm for movies is still strong, says Cinemark CEO
By Press Room
3 Mins read
Cinemark Holdings Inc. is basking in the success of summer blockbusters “Barbie” and “Oppenheimer,” which helped the movie theater chain deliver third-quarter…
Ben Graham influenced a host of billionaire investing titans, from the Oracle of Omaha to Seth Klarman, David Tepper and Mario Gabelli….
Investors should ‘be patient’ with beaten-down bank sector, buy-side fund manager says
By Press Room
3 Mins read
The clouds over bank stocks aren’t expected to clear anytime soon, fund manager Dave Ellison said, but some names remain attractive based…
Epic Games is the latest to take on Google in court over antitrust charges
By Press Room
4 Mins read
Add Epic Games Inc. to Google’s antitrust trial case load. The maker of the popular videogame “Fortnite,” which battled Apple Inc. AAPL,…
I’ve been looking ahead to Thursday’s release of the Beatles’ “new” song “Now and Then” — the work John Lennon recorded in…
Orange-juice futures suffer their biggest weekly decline in over 6 years after hitting record
By Press Room
1 Mins read
Orange-juice futures posted a drop of nearly 11% for the week on Friday, the largest such percentage decline since late March 2017,…
By Denny Jacob Stellar Bancorp board member and vice chairman George Martinez notified the company he won’t stand for re-election at its…
Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients
By Press Room
1 Mins read
By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.’s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval for Krazati…